… limit vaccine efficacy in advanced stages, which may make DC-based vaccines more …
advances in the development of DC-based vaccines, focuses on current barriers to success …

… of ex-vivo-activated T cells and natural killer cells, and cancer vaccines. Herein, we discuss
… cancer vaccines and how the current understanding of dendritic cell and T cell biology might …

Dendritic cells (DC) are specialized immune cells that play a critical role in promoting an
immune response against Ags, which can include foreign pathogenic Ags and self-tumor Ags. …

… While both vaccination strategies are forms of cell therapy … ’s cells, current protocols using
dendritic cells are considerably simpler and would be more widely available. Vaccination with …

Dendritic cells (DC) constitute a unique system of cells that induce, sustain and regulate
immune responses. Distributed as sentinels throughout the body, DC are poised to capture …

… Dendritic cells (DCs) are potent antigen presenting cells that … where they activate naïve
T cells. Although DCs are normally … Development of a dendritic cell (DC)-based vaccine for …

… Immunotherapy using dendritic cell (DC)-based vaccination is an approved approach for …
tumor cells in metastatic hormone-refractory cancer. Overall, although many DC vaccines have …

… responses to tumor-relevant epitopes that are not included in the original vaccine, particularly
relevant to dendritic cell (DC)-based vaccines Citation[16,17], further support the ability of …

… multiforme and the AV0113 vaccine for malignant glioma from … vaccine for acute myeloid
leukemia produced by the Dutch company DCPrime BV. Finally, antitumor DC-based vaccines …

… “cellular adjuvant” for a vaccine preparation aimed to induce … vaccine using autologous
myeloid derived dendritic cells (MD… -presenting functions of dendritic cells are impaired in HIV-1 …